In case of CLU, its inactivation resulted in hyperactivation of TAK1- NF-κB signaling axis and TAK1 inhibitor exhibited exquisite cytotoxicity to CLU deficient lung cancer cells. Here, NFKB1 is linked to lung carcinoma.